Fort Point Capital Partners »

Vertex Pharmaceuticals Incorporated shares owned by Fort Point Capital Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Fort Point Capital Partners from 13F filings

Historical chart of Fort Point Capital Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Fort Point Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Fort Point Capital Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $330k 820 402.70
2024-09-30 $320k 688 465.08
2024-06-30 $248k 530 468.72
2024-03-31 $228k 545 418.01
2023-12-31 $222k 545 406.89

More positions owned by Fort Point Capital Partners

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr National Mun Etf (MUB)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Cleanspark Com New (CLSK)
Apple (AAPL)
Schwab Strategic Tr Mun Bd Etf (SCMB)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Exxon Mobil Corporation (XOM)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Freshpet (FRPT)

View all positions for Fort Point Capital Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated